[{"type": "title", "data": "ED Allergic Reaction"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "<P>Anaphylaxis is highly likely if ONE of these criteria are met: </P><P>Criteria 1: Acute onset of an illness (minutes to several hours) involving skin, mucosal tissue or both (generalized hives, pruritus or flushing, swollen lips-tongue-uvula) and at least 1 of the following: respiratory compromise or hypotension (or associated symptoms) </P><P>&nbsp;</P><P>Criteria 2: 2 or more of the following that occur rapidly (minutes to several hours) after exposure to a likely allergen for that patient: skin or mucosal symptoms, respiratory symptoms or signs, hypotension (or associated symptoms), gastrointestinal symptoms (abdominal pain, nausea, or vomiting)</P><P>&nbsp;</P><P>Criteria 3: hypotension following minutes to several hours exposure to a known allergen for that patient: SBP less than 90 mmHg or reduced by 30% from baseline</P>"}, {"type": "note", "data": "For anaphylaxis, administration of adjunctive agents should not delay or substitute epinephrine administration if anaphylaxis is present. Role of adjunctive H1 and H2 antihistamines or steroids not certain in anaphylaxis. H1 antihistamines will relieve itching, angioedema, flushing, urticaria. Concurrent H2 antagonists may help reduce flushing or headache. Steroids may prevent protracted anaphylaxis and biphasic response. "}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "T;N, Constant Order, Continue to assess for recurrence of hives or pruritus, oral or facial edema, shortness of breath, wheezing, GI symptoms, or hypotension"}, {"type": "order", "data": "Notify Provider", "value": "checked"}, {"type": "sentence", "data": "T;N, Constant Order, Notify treating provider for recurrent or worsening allergic reaction symptoms"}, {"type": "order", "data": "Patient Education", "value": "checked"}, {"type": "sentence", "data": "T;N, Provide patient education for allergic reactions, prevention, diphenhydrAMINE and EPIPEN use"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "category", "data": "Medications"}, {"type": "order", "data": "diphenhydrAMINE", "value": ""}, {"type": "sentence", "data": "50 mg, IV Push, Injection, q6hr, PRN, Pruritus, T;N, 180 day(s)"}, {"type": "sentence", "data": "25 mg, IV Push, Injection, q6hr, PRN, Pruritus, T;N, 180 day(s)"}, {"type": "order", "data": "diphenhydrAMINE", "value": ""}, {"type": "sentence", "data": "50 mg, PO, Cap, q6hr, PRN, Pruritus, T;N, 180 day(s)"}, {"type": "sentence", "data": "25 mg, PO, Cap, q6hr, PRN, Pruritus, T;N, 180 day(s)"}, {"type": "order", "data": "loratadine", "value": ""}, {"type": "sentence", "data": "20 mg, PO, Tab, Once, NOW, T;N"}, {"type": "sentence", "data": "10 mg, PO, Tab, Once, NOW, T;N"}, {"type": "order", "data": "salbutamol CFC free 100 mcg/inh inhalation aerosol", "value": ""}, {"type": "sentence", "data": "2 puffs, via Aerochamber, MDI, q1hr, PRN, Shortness of Breath or wheezing, T;N, 180 day(s)"}, {"type": "sentence", "data": "4 puffs, via Aerochamber, MDI, q1hr, PRN, Shortness of Breath or wheezing, T;N, 180 day(s)"}, {"type": "sentence", "data": "6 puffs, via Aerochamber, MDI, q1hr, PRN, Shortness of Breath or wheezing, T;N, 180 day(s)"}, {"type": "order", "data": "famotidine", "value": ""}, {"type": "sentence", "data": "20 mg, IV Piggyback, Injection, Once, NOW, T;N"}, {"type": "order", "data": "famotidine", "value": ""}, {"type": "sentence", "data": "20 mg, PO, Tab, Once, NOW, T;N"}, {"type": "order", "data": "methylPREDNISolone sodium succinate", "value": ""}, {"type": "sentence", "data": "125 mg, IV Piggyback, Injection, Once, NOW, T;N"}, {"type": "order", "data": "ondansetron", "value": ""}, {"type": "sentence", "data": "4 mg, IV Piggyback, Injection, q8hr, PRN, Nausea or Vomiting, T;N, 180 day(s)"}, {"type": "sentence", "data": "8 mg, IV Piggyback, Injection, q8hr, PRN, Nausea or Vomiting, T;N, 180 day(s)"}, {"type": "order", "data": "predniSONE", "value": ""}, {"type": "sentence", "data": "50 mg, PO, Tab, Once, NOW, T;N"}, {"type": "order", "data": "dimenhyDRINATE 10 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "50 mg, IV Push, Injection, q6hr, PRN, Nausea, T;N, 180 day(s)"}, {"type": "sentence", "data": "25 mg, IV Push, Injection, q6hr, PRN, Nausea, T;N, 180 day(s)"}, {"type": "order", "data": "dimenhyDRINATE 50 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "50 mg, IM, Injection, q6hr, PRN, Nausea, T;N, 180 day(s)"}, {"type": "sentence", "data": "25 mg, IM, Injection, q6hr, PRN, Nausea, T;N, 180 day(s)"}, {"type": "order", "data": "dimenhyDRINATE 50 mg oral tablet", "value": ""}, {"type": "sentence", "data": "50 mg, PO, Tab, q6hr, PRN, Nausea, T;N, 180 day(s)"}, {"type": "sentence", "data": "25 mg, PO, Tab, q6hr, PRN, Nausea, T;N, 180 day(s)"}, {"type": "order", "data": "EPINEPHrine 1 mg/mL injectable solution", "value": ""}, {"type": "sentence", "data": "0.5 mg, IM, Injection, Once, NOW, T;N"}, {"type": "note", "data": "If patient is taking a beta blocker and is hypotensive following epinephrine, may consider glucagon "}, {"type": "order", "data": "glucagon", "value": ""}, {"type": "sentence", "data": "1 mg, IV Push, Injection, Once, NOW, T;N"}, {"type": "note", "data": "Placeholder for NH &quot;ED Vasopressors / Inotropes (Module)&quot;"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "Consult to Critical Care", "value": ""}, {"type": "sentence", "data": "T;N, Critical Care - Intensivist"}, {"type": "order", "data": "Consult to Registered Respiratory Therapy (RRT)", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "order", "data": "Consult to Internal Medicine", "value": ""}, {"type": "sentence", "data": "T;N, Internist - General"}, {"type": "order", "data": "Consult to Primary Care Provider", "value": ""}, {"type": "sentence", "data": "T;N, Family Practice"}]
